If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
ST. PAUL, Minn.–(HSMN NewsFeed)–EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity and other gastrointestinal disorders, announced today that, following a recent meeting with the U.S. Food a…
Devices, Gastroenterology, FDA
EnteroMedics, Maestro System, EMPOWER trial, VBLOC therapy
Posts from ‘January, 2010’
EnteroMedics Announces Regulatory Path Forward Following FDA Meeting
Ligand Completes Acquisition of Metabasis
SAN DIEGO–(HSMN NewsFeed)–Ligand Pharmaceuticals Incorporated (NASDAQ:LGND ) announced that it has completed the acquisition of Metabasis Therapeutics, Inc. (NASDAQ:MBRX ), following approval of the transaction by Metabasis stockholders yesterday. As a r…
Biopharmaceuticals, Mergers & Acquisitions
Ligand Pharmaceuticals, Metabasis Therapeutics
Pyng Laboratory Receives Health Canada License: FASTx(TM) Intraosseous Infusion System Now Available in Canada
VANCOUVER, BRITISH COLUMBIA, Jan 28 –(HSMN NewsFeed)– Pyng Clinical Corp. (TSX-V:PYT ) today announced the Company has received Health Canada regulatory clearance to market its new and improved FASTx Sternal Intraosseous Device, effective immediately. …
Devices, Regulatory
Pyng Medical, FASTx, Sternal Intraosseous Device
Life Spine(R) Announces FDA Clearance of DYNA-LINK(R) Spinal System and PRESIDIO(TM) Spinal Plating System
Systems significantly increase Life Spine’s presence in the thoracolumbar fusion space HOFFMAN ESTATES, Ill., Jan. 28 (HSMN NewsFeed) — Life Spine announced today that the U.S. Food and Drug Administration (FDA) has given 510(k) product management clearance t…
Devices, FDA, Neurosurgery, Orthopaedic
Life Spine, DYNA-LINK Spinal System, Spinal Plating
ZOLL Awarded Therapeutic Temperature Management Contract with HealthTrust Purchasing Group
CHELMSFORD, Mass.–(HSMN NewsFeed)–ZOLL Medical Corporation (NasdaqGS: ZOLL ), a manufacturer of clinical devices and related software solutions, announced today that HealthTrust Purchasing Group, LP (HealthTrust), a big healthcare group purchasing org…
Devices, Monitoring, Group Purchasing
ZOLL Medical, HealthTrust Purchasing, intravascular temperature management
Cephalon Announces Executive Leadership Changes
FRAZER, Pa., Jan. 28 (HSMN NewsFeed) — Cephalon, Inc., (Nasdaq: CEPH) today announced the promotion of 3 executives, Kevin Buchi, Wilco Groenhuysen and Alain Aragues. Kevin Buchi is promoted to a new position as Chief Operating Officer with respo…
Biopharmaceuticlas, Personnel
Cephalon
ZOLL Awarded Therapeutic Temperature Management Contract with HealthTrust Purchasing Group
CHELMSFORD, Mass.–(HSMN NewsFeed)–ZOLL Laboratory Corporation (NasdaqGS: ZOLL ), a manufacturer of clinical devices and related software solutions, announced today that HealthTrust Purchasing Group, LP (HealthTrust), a major healthcare group purchasing org…
Devices, Monitoring, Group Purchasing
ZOLL Clinical, HealthTrust Purchasing, intravascular temperature management
Abraxis BioScience Confirms Plan to Spin-off Abraxis Health in 2010 and Announces Management Structure
Abraxis BioScience to Continue Core Focus on Global Commercialization of ABRAXANE® Oncology Franchise, Robust Phase 3 Medical Program and Proprietary nab® Technology Platform Abraxis Health to Pioneer New Paradigm in Healthcare Delivery Rooted …
Biopharmaceuticals, Personnel
Abraxis BioScience, Abraxis Health
Invatec Completes its Maris Plus Self-Expanding Peripheral Stent System at LINC 2010
Tailored Stent for Superficial Femoral Artery Stenting now available LEIPZIG, Germany–(HSMN NewsFeed)–Invatec, a comprehensive innovator of interventional products, today launched its latest self-expanding peripheral stent system, Maris Plus in new 6,…
Devices, Interventional
Invatec, Maris Plus, peripheral stent, Peripheral Arterial Disease
EpiCept Receives Orphan Drug Designation for EpiCept NP-1 in U.S.
TARRYTOWN, N.Y.–(HSMN NewsFeed)–EpiCept Corporation (Nasdaq and Nasdaq OMX Stockholm Exchange: EPCT) announced today that EpiCeptTM NP-1 has been granted orphan drug designation by the U.S. Food and Drug Administration (FDA) for the treatment of post-her…
Biopharmaceuticals, FDA
EpiCept, orphan drug designation, NP-1, post-herpetic neuralgia
